Discovery of GLPG2737, a Potent Type 2 Corrector of CFTR for the Treatment of Cystic Fibrosis in Combination with a Potentiator and a Type 1 Co-corrector
Article in Journal of Medicinal Chemistry (March 2024)
The most recent citing publications are shown below. View all 31 publications that cite this research output on Dimensions.
Functional Consequences of CFTR Interactions in Cystic Fibrosis
Article in International Journal of Molecular Sciences (March 2024)
Recommended Tool Compounds for Modifying the Cystic Fibrosis Transmembrane Conductance Regulator Channel Variants
Article in ACS Pharmacology & Translational Science (March 2024)